Santhera Pharmaceuticals Holding AG (SANN)
SIX
Real-time Data
07:00 AM
Day's Range
15.8052 wk Range
9.38Overview - SANN - Santhera Pharmaceuticals Holding AG
Key Statistics
Valuation
Enterprise Value
240.54M
P/E (Trailing)
‪2.52‬
P/E (Forward)
‪94.00‬
PEG Ratio
‪94.00‬
Price / Sales (TTM)
‪3.15‬
EV / EBITDA
‪-7.39‬
Profitability
Gross Margin
‪86.33%‬
Profit Margin
‪-63.79%‬
Operating Margin
‪-4.07%‬
Return on Assets
‪-15.64%‬
Return on Equity
‪-620.02%‬
Ownership
Shares Outstanding
13.39M
Float
11.27M
Held by Insiders
‪14.56%‬
Held by Institutions
‪11.10%‬
Price stats
Beta
‪-0.27‬
50-Day Avg
‪15.44‬
200-Day Avg
‪14.82‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
2 analysts
Average price target
‪CHF 27.50‬Peers - SANN - Santhera Pharmaceuticals Holding AG
Peer Comparison
Compared with companies in Biotechnology listed on SIX.
- SANNSIXSanthera Pharmaceuticals Holding AG253.69MMarket Cap+13.52%52-week change2.53P/E (Trailing)‪-63.79%‬Profit Margin
- BIONSIXBB Biotech AG3.06BMarket Cap+42.25%52-week change2.26P/E (Trailing)‪127.31%‬Profit Margin
- BSLNSIXBasilea Pharmaceutica Ltd800.76MMarket Cap+28.27%52-week change20.57P/E (Trailing)‪21.17%‬Profit Margin
- BIOVSIXBioVersys AG145.03MMarket Cap-1.20%52-week change-6.43P/E (Trailing)‪-386.62%‬Profit Margin
- ADXNSIXAddex Therapeutics Ltd4.25MMarket Cap-120.61%52-week change-0.44P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - SANN - Santhera Pharmaceuticals Holding AG
About
Santhera Pharmaceuticals Holding AG is a Swiss specialty pharmaceutical company headquartered in Pratteln, Switzerland, dedicated to the research, development, and commercialization of innovative medicines for patients with rare and debilitating diseases. The company primarily targets unmet medical needs in…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
